Antodine

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Antodine

Property Description
Active Ingredient Famotidine
Form Tablet, Liquid Suspension, IV Solution
Pharmacological Class Histamine H2 Receptor Antagonist (H2RA)
General Purpose Reduction of Gastric Acid Secretion
Origin Synthetic

What Type of Medicine is Antodine (Famotidine)?

Antodine is a commercially recognized brand name for the medication containing the active ingredient Famotidine. This drug is classified as a Histamine H2 Receptor Antagonist (H2RA), or H2 blocker, and is available in both over-the-counter and prescription-only formulations. Antodine is a synthetic, single-ingredient antisecretory agent whose function is centered on controlling acid production. The medication exhibits selective action against the H2 receptors, a distinguishing property within its therapeutic class.

Composition and Available Forms of Antodine

The foundation of Antodine is the chemically synthesized compound Famotidine. The medication is made available to patients in multiple dosage forms, facilitating various routes of administration, including standard oral tablets, chewable tablets, an oral liquid suspension, and a solution for intravenous (IV) use. The availability of forms such as the liquid suspension allows for tailored administration, supporting the needs of pediatric patients or those who have difficulty swallowing. The formulation relies on pharmaceutical excipients or an aqueous base to ensure effective and stable delivery of the active substance.

What is the General Purpose of Antodine?

The general purpose of Antodine is to reduce the volume and acidity of gastric acid secreted into the stomach. The drug works by competitively blocking the H2 receptors on the stomach’s parietal cells, thereby interrupting the major signaling pathway for acid production. This action suppresses both resting and nocturnal gastric acid secretion. The overall benefit is the protection of the upper digestive tract lining from irritation and subsequent damage caused by high acid levels.

Regulatory References

  1. Famotidine: MedlinePlus Drug Information
  2. Famotidine - StatPearls - NIH

What side effects are possible with Antodine?

Possible Side Effects and Safety Information

The safety profile of Antodine (Famotidine) is formally documented in government regulatory sources, which classify adverse reactions based on their frequency and the system-organ class involved. All statements regarding safety are derived exclusively from these official regulatory documents.

Adverse Reaction Frequencies

Side effects are categorized by official regulatory bodies, with Common reactions (occurring in ge 1% of individuals) typically including headache, dizziness, constipation, and diarrhea. Reactions classified as Uncommon or Rare involve systems such as the skin (rash, pruritus) and the liver (increase in liver enzymes).

Serious and Clinically Significant Reactions

Official labeling recognizes the potential for rare, yet clinically significant, adverse reactions, particularly affecting the nervous and cardiovascular systems. These reactions, which are classified as Very Rare, include convulsions and seizures (including Grand mal type), as well as arrhythmias and QT prolongation. Severe systemic reactions, such as anaphylaxis and Toxic epidermal necrolysis, are also documented safety events.

Population-Specific Safety Considerations

The regulatory safety profile notes specific considerations for certain patient populations. Individuals with renal impairment (moderate to severe) are documented to have an increased risk for CNS adverse reactions (confusion, agitation, seizures) and QT prolongation. Similarly, older adults are noted to have a higher potential for Central Nervous System adverse reactions. The official label requires pre-screening for gastric malignancy before initiating therapy, as the absence of gastrointestinal symptoms does not preclude its presence, and notes that the medicine is contraindicated in patients with a history of serious hypersensitivity to H2-receptor antagonists.

Overdose and Emergency Response

The official regulatory profile for Antodine (Famotidine) overdose describes a range of clinical presentations and serious potential outcomes. Documented manifestations involve the Central Nervous System (CNS), including signs such as confusion, disorientation, agitation, and, in severe cases, seizures or lethargy. Systemic symptoms, such as dizziness, slurred speech, and headache, are also noted in regulatory labeling. The most severe outcomes explicitly documented in official sources relate to the Cardiovascular System, where excessive exposure has been associated with life-threatening ventricular arrhythmias, including ventricular tachycardia (Torsade de pointes), ventricular fibrillation, and ventricular asystole.

Immediate medical attention is mandated by regulatory agencies upon the ingestion of an excessive amount. The official instruction is to seek professional assistance or contact a Poison Control Center right away. Management of an overdose is formally defined as symptomatic and supportive treatment, often requiring procedures like ECG monitoring and laboratory testing, as described in prescribing information. Special considerations are noted for elderly patients and individuals with moderate to severe renal impairment, as these groups face an increased risk of CNS adverse reactions due to higher systemic drug exposure.

Therapeutic Uses of Antodine

Antodine Quick Facts

  • Active Duodenal Ulcer: Used to manage active sores in the lining of the small intestine.
  • Gastroesophageal Reflux Disease (GERD): May offer symptomatic relief for acid reflux.
  • Pathological Hypersecretory Conditions: Contributes to the management of conditions like Zollinger-Ellison Syndrome.

Antodine is a medication utilized for the therapeutic support of various gastrointestinal conditions where the goal is to manage the effects of stomach acid. It is indicated for the treatment of active duodenal ulcers and gastric ulcers, which involve the presence of sores on the stomach or small intestine lining. The medication works to support the resolution of these ulcers.

Additionally, Antodine is used for the management of symptomatic nonerosive gastroesophageal reflux disease (GERD). In this context, it may provide symptomatic relief for associated discomfort, such as heartburn. It is also utilized in the treatment of erosive esophagitis that may occur as a result of GERD.

The therapeutic domains for Antodine also include addressing pathological hypersecretory conditions, such as Zollinger-Ellison Syndrome, where the stomach produces an unusually high volume of acid. Furthermore, it is approved for reducing the risk of recurrence of duodenal ulcers following initial healing.

Eligibility and Restrictions for Use

Who can and cannot use Antodine?

The population eligibility for Antodine (Famotidine) is defined by official regulatory criteria, focusing on drug allergy, age, and organ function.

Classification Population Status
Absolute Contraindication Patients with a history of serious hypersensitivity reactions to Famotidine or any other H2 receptor antagonist.
Conditional Use/Restriction Adults with Moderate/Severe Renal Impairment (CCr < 50 mL/min): Use requires a reduction in the daily dosage to mitigate the risk of Central Nervous System (CNS) adverse effects.
Age-Group Eligibility Adults and Children 1 year of age are approved for use in most indications. Infants < 1 year and neonates have officially not established safety and effectiveness for certain uses.
Pregnancy and Lactation Use during pregnancy is not recommended unless clearly necessary. Use during lactation is not recommended as the drug is excreted in breast milk.
Pre-screening Condition The presence of gastric malignancy must be excluded prior to treating gastric ulcers with Antodine.

These rules establish that Antodine is generally suitable for most adults and children over one year but is strictly prohibited for those with specific drug allergies. Usage is severely restricted or conditional for individuals with impaired kidney function, pregnant or nursing women, and infants.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define Antodine's interaction profile based on its pharmacological action and metabolic clearance. The primary documented pharmacokinetic (PK) interaction stems from Antodine’s ability to reduce gastric acid.

Interaction Type Interacting Substance/Condition Official Outcome Restriction/Caution
PK (pH-Dependent) Drugs dependent on gastric pH for absorption Significant reduction in systemic exposure of the co-administered drug. Not recommended with drugs like dasatinib, delavirdine mesylate, cefditoren, and fosamprenavir.
PK (Metabolic) Tizanidine ( CYP1 A2 substrate) Substantial increases in Tizanidine blood concentrations. Avoid concomitant use, if possible.
PK (Clearance) Renal Impairment (moderate/severe) Higher Antodine systemic exposure (reduced clearance). Increased risk of adverse reactions in this population.

These patterns establish regulatory constraints on co-administration to mitigate reduced efficacy of the interacting medicine or excessive exposure to either drug. Regarding non-medicinal products, the interaction with food is noted as having no clinical consequence, and no clinically significant interaction pattern with alcohol or herbal products is formally documented in core regulatory labels.

Mechanism of Action

Antodine is a small-molecule inhibitor which exhibits high-affinity, non-competitive binding to the A1beta Receptor (A1 R) located in the osteoclast cell membrane. This receptor interaction prevents the A1beta-mediated activation of the NFkappa B signaling pathway.

The subsequent modulation of the A1beta/ NFkappa B cascade downregulates the transcription of osteoclast-specific genes. These target genes include those encoding for key bone-resorbing proteins, such as cathepsin K (CTSK) and the TRAP enzyme. This disruption of the downstream signaling cascade is required for full osteoclast function. The result is a reduction in the expression of bone-resorbing proteins and a decrease in overall osteoclast activity.

Dosage and Administration Information

How to use Antodine (Famotidine) — Administration Guidelines

The instructions for Antodine (Famotidine) use are structured around key domains that define the standardized administration of the medicine.

Administration Scope

Instruction Detail
Route of administration Oral (tablets, suspension) and Intravenous (IV). The IV route is reserved for hospitalized patients unable to take oral medication.
Dosing schedule Active Ulcer: 40 mg once daily at bedtime OR 20 mg twice daily. Maintenance: 20 mg once daily at bedtime. Hypersecretory Conditions: Starting dose 20 mg every 6 hours, adjusted up to a maximum of 160 mg every 6 hours.
Timing in relation to meals (if applicable) Oral doses may be taken with or without food.
Preparation requirements (if applicable) The oral suspension must be shaken vigorously prior to use. IV solution requires dilution before infusion.
Age-group administration rules Renal Impairment (CrCl < 60 mL/min): Dose must be reduced or interval prolonged (e.g., to 36 or 48 hours) to prevent accumulation.
Missed-dose rules Take a missed dose as soon as remembered, unless it is near the time for the next dose, in which case the missed dose should be skipped. Do not double the dose.
Special procedural conditions IV Administration: Injection must be administered slowly, over a minimum of 2 minutes for a bolus or 15 to 30 minutes for an infusion.

Connection to the overall use protocol

The administration protocol for Antodine is defined by the dosing regimen, which varies based on the specific clinical goal (e.g., acute treatment versus maintenance), and the frequency pattern. Adherence to the prescribed time-related rules, such as taking the medicine independent of meal times, is important, as are the adjustments to the dose or interval if renal impairment is present, ensuring standardized delivery.

Recent Clinical Evidence

Research evidence / Overview of Studies for Antodine


Evidence for Healing Active Duodenal Ulcers

Research exploring the use of Antodine for active duodenal ulcers was largely based on short-term, controlled clinical trials involving adults. Studies monitored whether the ulcer healed, often confirmed by an endoscopy, and they also tracked patient-reported outcomes describing perceived discomfort and the quantity of antacids used. Studies reported measurements of healing rates, and differences were observed between the group receiving Antodine and the corresponding placebo groups at several time points.

However, follow-up durations were limited for the acute treatment phase (typically four to eight weeks). The research focused mainly on initial healing, and comparative evidence is lacking for certain newer drug classes in the primary evidence base.


Evidence for Preventing Duodenal Ulcer Recurrence (Maintenance Therapy)

Studies explored the use of Antodine to prevent duodenal ulcers from recurring once they had initially healed. This research examined outcomes reflecting daily functioning over intermediate-term, placebo-controlled trials, typically six to twelve months. These maintenance studies monitored patterns related to ulcer recurrence, which were observed to be lower in the populations receiving Antodine compared to the corresponding placebo groups across the defined time intervals.

It is important to note that the data show patterns related to recurrence prevention primarily over intermediate periods, as the longest duration observed in the key controlled studies was generally limited to one year. Therefore, long-term effects are not fully established beyond twelve months.


Evidence for Gastroesophageal Reflux Disease (GERD) and Esophagitis

Antodine was studied for both the symptomatic relief of non-erosive GERD and the healing of erosive esophagitis. Studies focusing on short-term symptom changes documented differences in the reported frequency of episodic discomfort when comparing the Antodine groups to placebo groups. For erosive esophagitis, findings described patterns of endoscopic healing, which were observed in varying proportions of patients receiving Antodine over periods up to twelve weeks. Evidence quality varies across studies, and the data for non-erosive GERD are still emerging, as the primary endpoints often rely on subjective patient-reported outcomes.

Key Studies & References

  1. Systematic Review and Meta-Analysis of H2 Receptor Antagonists for the Treatment of Duodenal Ulcer

Frequently Asked Questions (FAQ)

Common questions about Antodine (FAQ)


Q: How quickly does Antodine start working?

Official regulatory documents indicate that the medicine’s primary effect of reducing gastric acid secretion typically begins within one hour after taking an oral dose. This describes the initial onset of the drug's pharmacological action.


Q: How long can I expect to take Antodine?

The expected duration of use is defined in the official prescribing information and is condition-specific. Antodine may be used for short-term acute therapy (lasting several weeks, for instance) and longer-term maintenance therapy, which has been studied for periods up to one year to help reduce the chance of recurrence.


Q: Is Antodine only for short-term use?

No, official regulatory documents define uses for both short-term treatment (for conditions like active ulcers) and longer-term maintenance therapy. The duration of therapy depends on the specific condition being addressed as prescribed by a healthcare professional.


Q: What is the main goal of treatment with Antodine?

The medicine’s primary therapeutic purpose, as stated in regulatory documents, is the reduction of gastric acid secretion in the stomach. This action is intended to promote healing or to relieve symptoms associated with acid-related conditions.


Q: Is Antodine the same type of medicine as [similar competing drug name]?

Antodine (Famotidine) is formally classified as a Histamine H2 Receptor Antagonist ( H2 RA), or H2 blocker. Other acid-reducing medicines may belong to different pharmacological classes, such as Proton Pump Inhibitors (PPIs). Official information defines Antodine by its specific drug class.


Q: Is there a generic version of Antodine available?

Yes. The active ingredient in Antodine, Famotidine, is available in generic formulations. These include both prescription-strength and over-the-counter options, as verified in official drug listings like the FDA Orange Book.


Q: Is Antodine a narcotic or controlled substance?

Antodine (Famotidine) is not listed as a narcotic or controlled substance by government drug authorities. Regulatory classification lists indicate that it is not associated with risk of dependence or addiction.


Q: Does Antodine have a risk of dependence or addiction?

No. Regulatory classification lists indicate that Antodine (Famotidine) is not classified as a controlled substance and is not associated with risk of dependence or addiction.


Q: Why is Antodine prescribed for [secondary, less common condition]?

Official documents list multiple approved indications for the medicine. Beyond common uses, it is also prescribed for the treatment of conditions associated with very high levels of acid production, such as Zollinger-Ellison Syndrome.


Q: What is the primary way Antodine is eliminated from the body?

The primary way the absorbed medicine is removed from the body is through the kidneys via renal excretion. Official labeling notes that dose adjustments may be required for individuals with kidney impairment.


Q: Can older adults use Antodine?

Yes, use in older adults is documented in regulatory sources. Official information notes that this population has a higher potential for Central Nervous System (CNS) adverse reactions. Official labeling notes that caution or dosage adjustment may be necessary.


Q: Does Antodine affect sleep?

Yes, official regulatory labeling includes insomnia (difficulty sleeping) as an uncommon adverse reaction associated with the use of Antodine.


Q: Can I drive or operate machinery after taking Antodine?

Official drug labeling includes warnings that Antodine may cause side effects such as dizziness or headache. Official drug labeling often includes general warnings that if patients experience these symptoms, caution should be exercised when driving or operating machinery.


Q: Is it okay to drink alcohol in moderation while on Antodine?

Core regulatory labels state that no clinically significant interaction between Antodine and alcohol has been formally documented. However, official documentation suggests alcohol may exacerbate symptoms of the underlying condition.


Q: Can Antodine interact with vitamins or supplements?

Official drug labeling focuses on interactions with prescribed medicines. A review of core regulatory documents indicates no specific, clinically significant interactions formally documented with general vitamins or common nutritional supplements.


Q: Can I take pain relievers like ibuprofen with Antodine?

Regulatory sources note that Antodine reduces gastric acid, which can affect the absorption of other medicines, particularly those that require an acidic environment. Official labeling states that caution should be exercised when co-administering Antodine with other medications.


Q: Can Antodine be crushed or split?

The official instructions specify standard administration for tablets and liquid suspension. Since no instructions for crushing or splitting standard tablets are provided in the regulatory labeling, the tablet form is generally intended to be swallowed whole.


Q: Can Antodine cause problems with my liver or kidneys?

Regulatory documents note increased liver enzymes as an uncommon or rare side effect. Official labeling indicates that patients with kidney impairment may require dosage adjustment to manage the increased risk of adverse effects due to how the drug is eliminated.


Q: Does Antodine cause any changes to skin or hair?

Regulatory labeling notes rare side effects affecting the skin, such as rash, pruritus (itching), or urticaria (hives). Rare cases of hair loss (alopecia) have also been documented in regulatory sources.


Q: Does Antodine cause weight gain or loss?

A review of core regulatory documents indicates that weight gain or weight loss is not listed as a common or specific adverse reaction associated with Antodine.


Q: Do other medicines make Antodine work less effectively?

Regulatory documents primarily focus on how Antodine affects the absorption of other medicines. There are no widely documented, clinically significant interactions where another medicine significantly decreases the effectiveness of Antodine itself.


Q: Are there any long-term health effects noted for Antodine?

The primary clinical trial data described in regulatory sources provided evidence for use over periods up to one year for maintenance therapy. Long-term health effects beyond this one-year period are not fully established in the core evidence base.


Q: What if Antodine doesn't seem to be working for me after a few weeks?

Official information indicates that for some conditions, full effectiveness is typically evaluated by a healthcare professional after the specified treatment duration, often several weeks. A perceived lack of improvement over the expected treatment period should be discussed with the prescribing healthcare professional.


Q: What is the difference between Antodine and a placebo in studies?

Clinical research evidence indicates that Antodine groups demonstrated favorable differences in healing rates and recurrence rates for conditions like ulcers and GERD, compared to the corresponding placebo groups across the monitored time periods.


Q: What percentage of people in studies reported feeling better on Antodine?

Regulatory documents report the observed rates for specific clinical endpoints, such as rates of ulcer healing or symptom relief, in Antodine groups compared to placebo groups across studies.


Q: What patient groups are specifically mentioned in research for Antodine?

The clinical studies that form the primary evidence base for Antodine largely involved the adult population and, for certain indications, pediatric patients ge 1 year of age.


Q: What studies have been conducted on Antodine?

Regulatory sources outline that the evidence is based primarily on short-term, controlled clinical trials. These studies used endpoints such as endoscopically confirmed ulcer healing and monitored recurrence patterns for maintenance therapy.

How should Antodine be stored and disposed of?

The storage and disposal instructions for Antodine (Famotidine) are based on regulatory labeling to maintain the product's stability.

Storage Category Requirement
Tablets Temperature Store at controlled room temperature: 20 C to 25 C (68 F to 77 F).
Protection Keep the tablets protected from moisture. All forms must be protected from freezing.
Oral Suspension Stability The reconstituted liquid is stable for 30 days when stored at room temperature or refrigerated; any unused portion must be discarded after 30 days.
Child Safety Store the medicine out of the sight and reach of children.

Disposal should utilize an authorized drug take-back program. If a program is unavailable, unused medicine must be mixed with an unappealing substance (like dirt or coffee grounds) and placed in a sealed container before discarding in household trash. Famotidine is not on the list of medicines recommended for disposal by flushing.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Antodine found in:

A-Z Index: